| 12194110 |
PD-L1 binding polypeptides for imaging |
Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, David Fabrizio +6 more |
2025-01-14 |
|
| 11858995 |
Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia |
Brian Elliott, Jenny Jianlin Chen, Tahamtan Ahmadi, Christopher Chiu, Esther BREIJ +1 more |
2024-01-02 |
$11,135,000 |
| 11845805 |
Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma |
Brian Elliott, Tahamtan Ahmadi, Christopher Chiu, Esther BREIJ, Ida HIEMSTRA |
2023-12-19 |
$9,322,000 |
| 11608383 |
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma |
Brian Elliott, Tahamtan Ahmadi, Christopher Chiu, Esther BREIJ, Ida HIEMSTRA |
2023-03-21 |
$12,640,000 |
| 11352440 |
Antibodies against CD73 and uses thereof |
Nils Lonberg, Alan J. Korman, Bryan C. BARNHART, Aaron P. YAMNIUK, Mohan Srinivasan +13 more |
2022-06-07 |
|
| 11344639 |
PET imaging with PD-L1 binding polypeptides |
Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, David Fabrizio +7 more |
2022-05-31 |
|
| 11173219 |
PD-L1 binding polypeptides for imaging |
Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, David Fabrizio +6 more |
2021-11-16 |
|
| 11103579 |
Combination of DR5 agonist and anti-PD-1 antagonist and methods of use |
Bryan C. BARNHART |
2021-08-31 |
|
| 10604575 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2020-03-31 |
|
| 10584170 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2020-03-10 |
|
| 10577423 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2020-03-03 |
|
| 10406251 |
PD-L1 binding polypeptides for imaging |
Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, David Fabrizio +6 more |
2019-09-10 |
|
| 10323092 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2019-06-18 |
|
| 10323093 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2019-06-18 |
|
| 10316090 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2019-06-11 |
|
| 10316091 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2019-06-11 |
|
| 10308714 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2019-06-04 |
|
| 10266594 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |
|
| 10266595 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |
|
| 10266596 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |
|
| 10167343 |
Antibodies against CD73 |
Nils Lonberg, Alan J. Korman, Bryan C. BARNHART, Aaron P. YAMNIUK, Mohan Srinivasan +13 more |
2019-01-01 |
|
| 10138299 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2018-11-27 |
|
| 10100129 |
Antibodies against CD73 and uses thereof |
Nils Lonberg, Alan J. Korman, Bryan C. BARNHART, Aaron P. YAMNIUK, Mohan Srinivasan +13 more |
2018-10-16 |
|
| 10072082 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2018-09-11 |
|
| 9856320 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton |
2018-01-02 |
|